[Staphylococcus aureus nosocomial infections in critically ill patients admitted in intensive care units]
- PMID: 16759562
- DOI: 10.1157/13087841
[Staphylococcus aureus nosocomial infections in critically ill patients admitted in intensive care units]
Abstract
Background and objective: To investigate the frequency of nosocomial infections caused by Staphylococcus aureus in critically ill patients admitted to Spanish intensive care units (ICUs) and to describe the characteristics and outcome of patients in whom this pathogen was isolated.
Patients and method: Prospective, observational, and multicenter study. All patients admitted during one or 2 months to the participating ICUs in the National Nosocomial Infection Surveillance Study (ENVIN) between 1997 and 2003 were included. Patients were classified as infected by S. aureus, infected by other microorganisms, and without nosocomial infection.
Results: A total of 34,914 patients were controlled of whom 3,450 (9.9%) had acquired a nosocomial infection during his/her ICU stay (16.0 infections per 100 patients). In 682 (19.8%) patients, a total of 775 infectious episodes in which one of the microorganisms isolated was S. aureus were documented (cumulative incidence 2.2 episodes of S. aureus infection per 100 patients). There was a predominance of S. aureus infection in patients with pneumonia associated with mechanical ventilation (21.4%) and in patients with catheter-related bacteremia (13%). Independent variables associated with S. aureus infection were male sex (odds ratio [OR] = 1.25; 95% confidence interval [CI], 1.03-1.52) and underlying trauma pathology (OR = 1.72, 95%; 95%CI, 1.26-2.35), whereas an older age has been a protective factor (OR = 0.90; 95%CI, 0.84-0.96). Mortality in patients with S. aureus infection was significantly higher than in infections caused by other microorganisms, and in both cases higher than in patients without infection (34.5%, 30.3%, and 10.7%, respectively). In 208 (30.5%) patients, infections due to methicillin-resistant S. aureus were diagnosed, which in turn had increased significantly over the years (p = 0.001). Mortality in patients with methicillin-resistant S. aureus infection was 35.1% compared with 34.2% in patients with methicillin sensitive S. aureus infections (p = NS).
Conclusions: S. aureus was isolated in 19.8% of patients with ICU-acquired infection, particularly in relation to pneumonia in mechanically ventilated patients. Mortality in patients with S. aureus infection was higher than that in patients with infections due to other microorganisms and patients without infection. In contrast, differences in the outcome of patients with infections caused by methicillin-sensitive or methicillin-resistant S. aureus were not found.
Similar articles
-
Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections.Am J Infect Control. 2006 Feb;34(1):1-5. doi: 10.1016/j.ajic.2005.07.005. Am J Infect Control. 2006. PMID: 16443085
-
Risk factors for methicillin-resistant Staphylococcus aureus colonisation or infection in intensive care units and their reliability for predicting MRSA on ICU admission.Infez Med. 2016 Sep 1;24(3):201-9. Infez Med. 2016. PMID: 27668900
-
[Enterococcal infections in critically ill patients admitted to ICU].Med Clin (Barc). 2003 Sep 13;121(8):281-6. doi: 10.1016/s0025-7753(03)73919-0. Med Clin (Barc). 2003. PMID: 14499081 Spanish.
-
Hospital-acquired pneumonia: methicillin resistance and intensive care unit admission.Am J Med. 1998 May 29;104(5A):17S-23S. doi: 10.1016/s0002-9343(98)00151-x. Am J Med. 1998. PMID: 9684654 Review.
-
Methicillin-resistant Staphylococcus aureus infections in ICU patients.Anesthesiol Clin North Am. 2004 Sep;22(3):405-35, vi. doi: 10.1016/j.atc.2004.04.006. Anesthesiol Clin North Am. 2004. PMID: 15325711 Review.
Cited by
-
Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function.Eur J Clin Microbiol Infect Dis. 2011 May;30(5):635-43. doi: 10.1007/s10096-010-1133-6. Epub 2011 Jan 12. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21225305
-
Evaluation of antimicrobial efficacy of flavonoids of withania somnifera L.Indian J Pharm Sci. 2011 Jul;73(4):473-8. doi: 10.4103/0250-474X.95656. Indian J Pharm Sci. 2011. PMID: 22707839 Free PMC article.
-
Antimicrobial properties of a novel copper-based composite coating with potential for use in healthcare facilities.Antimicrob Resist Infect Control. 2019 Jan 5;8:3. doi: 10.1186/s13756-018-0456-4. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 30627427 Free PMC article.
-
Gram-positive cocci infections in intensive care: guide to antibacterial selection.Drugs. 2006;66(6):751-68. doi: 10.2165/00003495-200666060-00003. Drugs. 2006. PMID: 16706550
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous